A Novel Association between YKL-40, a Marker of Structural Lung Disease, and Short Telomere Length in 10-Year-Old Children with Bronchopulmonary Dysplasia
Open Access
- 24 January 2021
- Vol. 8 (2), 80
- https://doi.org/10.3390/children8020080
Abstract
Extremely preterm infants are born with immature lungs and are exposed to an inflammatory environment as a result of oxidative stress. This may lead to airway remodeling, cellular aging and the development of bronchopulmonary dysplasia (BPD). Reliable markers that predict the long-term consequences of BPD in infancy are still lacking. We analyzed two biomarkers of cellular aging and lung function, telomere length and YKL-40, respectively, at 10 years of age in children born preterm with a history of BPD (n = 29). For comparison, these markers were also evaluated in sex-and-age-matched children born at term with childhood asthma (n = 28). Relative telomere length (RTL) was measured in whole blood with qPCR and serum YKL-40 with ELISA, and both were studied in relation to gas exchange and the regional ventilation/perfusion ratio using three-dimensional V/Q-scintigraphy (single photon emission computer tomography, SPECT) in children with BPD. Higher levels of YKL-40 were associated with shorter leukocyte RTL (Pearson’s correlation: −0.55, p = 0.002), but were not associated with a lower degree of matching between ventilation and perfusion within the lung. Serum YKL-40 levels were significantly higher in children with BPD compared to children with asthma (17.7 vs. 13.2 ng/mL, p < 0.01). High levels of YKL-40 and short RTLs were associated to the need for ventilatory support more than 1 month in the neonatal period (p < 0.01). The link between enhanced telomere shortening in childhood and structural remodeling of the lung, as observed in children with former BPD but not in children with asthma at the age of 10 years, suggests altered lung development related to prematurity and early life inflammatory exposure. In conclusion, relative telomere length and YKL-40 may serve as biomarkers of altered lung development as a result of early-life inflammation in children with a history of prematurity.Keywords
This publication has 37 references indexed in Scilit:
- Oxygen Disrupts Human Fetal Lung Mesenchymal Cells. Implications for Bronchopulmonary DysplasiaAmerican Journal of Respiratory Cell and Molecular Biology, 2019
- Oxygen therapy of the newborn from molecular understanding to clinical practicePediatric Research, 2018
- Stereotypic Immune System Development in Newborn ChildrenCell, 2018
- Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective studyThe Lancet Respiratory Medicine, 2015
- Biomarkers of progression of chronic obstructive pulmonary disease (COPD)2014
- Perinatal Complications and Aging Indicators by MidlifePublished by American Academy of Pediatrics (AAP) ,2014
- New Asthma Biomarkers: Shorter Telomeres, Longer Disease?American Journal of Respiratory and Critical Care Medicine, 2014
- Preterm Resuscitation With Low Oxygen Causes Less Oxidative Stress, Inflammation, and Chronic Lung DiseasePediatrics, 2009
- Vascular Endothelial Growth Factor Gene Therapy Increases Survival, Promotes Lung Angiogenesis, and Prevents Alveolar Damage in Hyperoxia-Induced Lung InjuryCell Metabolism, 2005
- Bronchopulmonary dysplasia—oxidative stress and antioxidantsSeminars in Neonatology, 2003